The FDA has granted fast track designation to LBS-007 for the treatment of patients with acute myeloid leukemia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback